CAMLINFINESpecialty Chemicals
Camlin Fine Sciences Ltd — Profit & Loss Statement
₹96.93
-6.09%
Camlin Fine Sciences Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | -0.01 Cr | -2.13 Cr | -3.91 Cr | -0.31 Cr | — |
| Tax Rate For Calcs | 0.00 | 0.10 | 0.30 | 0.36 | — |
| Normalized EBITDA | 211.46 Cr | 226.96 Cr | 197.05 Cr | 180.05 Cr | — |
| Total Unusual Items | -10.81 Cr | -22.14 Cr | -13.04 Cr | -0.87 Cr | — |
| Total Unusual Items Excluding Goodwill | -10.81 Cr | -22.14 Cr | -13.04 Cr | -0.87 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 68.48 Cr | 65.08 Cr | 52.11 Cr | 60.68 Cr | — |
| Reconciled Depreciation | 73.67 Cr | 78.61 Cr | 62.51 Cr | 55.96 Cr | — |
| Reconciled Cost Of Revenue | 870.08 Cr | 792.81 Cr | 830.37 Cr | 770.75 Cr | — |
| EBITDA | 200.65 Cr | 204.82 Cr | 184.02 Cr | 179.18 Cr | — |
| EBIT | 126.98 Cr | 126.21 Cr | 121.50 Cr | 123.21 Cr | — |
| Net Interest Income | -76.59 Cr | -72.39 Cr | -48.56 Cr | -34.36 Cr | — |
| Interest Expense | 77.51 Cr | 67.62 Cr | 41.13 Cr | 29.23 Cr | — |
| Interest Income | 10.44 Cr | 1.77 Cr | 1.09 Cr | 1.75 Cr | — |
| Normalized Income | 79.27 Cr | 85.10 Cr | 61.23 Cr | 61.24 Cr | — |
| Net Income From Continuing And Discontinued Operation | -139.05 Cr | -92.75 Cr | 52.11 Cr | 60.68 Cr | — |
| Total Expenses | 1.48K Cr | 1.27K Cr | 1.51K Cr | 1.30K Cr | — |
| Rent Expense Supplemental | 9.85 Cr | 9.74 Cr | 8.87 Cr | 6.14 Cr | — |
| Diluted Average Shares | 17.50 Cr | 17.14 Cr | 17.35 Cr | 14.68 Cr | — |
| Basic Average Shares | 17.31 Cr | 16.91 Cr | 17.13 Cr | 14.42 Cr | — |
| Diluted EPS | -8.03 | -5.49 | 3.33 | 4.43 | — |
| Basic EPS | -8.03 | -5.49 | 3.37 | 4.50 | — |
| Diluted NI Availto Com Stockholders | -139.05 Cr | -92.75 Cr | 57.73 Cr | 60.68 Cr | — |
| Net Income Common Stockholders | -139.05 Cr | -92.75 Cr | 57.73 Cr | 60.68 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | -5.62 Cr | 0.00 | — |
| Net Income | -139.05 Cr | -92.75 Cr | 52.11 Cr | 60.68 Cr | — |
| Minority Interests | 19.07 Cr | 12.12 Cr | 12.30 Cr | 0.31 Cr | — |
| Net Income Including Noncontrolling Interests | -158.12 Cr | -104.88 Cr | 39.81 Cr | 60.37 Cr | — |
| Net Income Discontinuous Operations | -207.52 Cr | -157.84 Cr | — | — | — |
| Net Income Continuous Operations | 49.40 Cr | 52.96 Cr | 39.81 Cr | 60.37 Cr | — |
| Tax Provision | 0.07 Cr | 5.63 Cr | 40.57 Cr | 33.61 Cr | — |
| Pretax Income | 49.47 Cr | 58.59 Cr | 80.38 Cr | 93.98 Cr | — |
| Other Non Operating Income Expenses | 2.46 Cr | 9.08 Cr | 4.49 Cr | 5.00 Cr | — |
| Special Income Charges | -10.81 Cr | -26.84 Cr | -13.34 Cr | -4.17 Cr | — |
| Other Special Charges | 8.55 Cr | 0.15 Cr | 12.19 Cr | 0.23 Cr | — |
| Write Off | 0.24 Cr | 26.69 Cr | 0.65 Cr | 0.03 Cr | — |
| Restructuring And Mergern Acquisition | 2.02 Cr | — | — | — | — |
| Net Non Operating Interest Income Expense | -76.59 Cr | -72.39 Cr | -48.56 Cr | -34.36 Cr | — |
| Total Other Finance Cost | 9.52 Cr | 6.54 Cr | 8.53 Cr | 6.88 Cr | — |
| Interest Expense Non Operating | 77.51 Cr | 67.62 Cr | 41.13 Cr | 29.23 Cr | — |
| Interest Income Non Operating | 10.44 Cr | 1.77 Cr | 1.09 Cr | 1.75 Cr | — |
| Operating Income | 156.12 Cr | 163.74 Cr | 161.99 Cr | 106.05 Cr | — |
| Operating Expense | 609.39 Cr | 479.68 Cr | 678.94 Cr | 527.61 Cr | — |
| Other Operating Expenses | 290.34 Cr | 207.61 Cr | 380.32 Cr | 255.43 Cr | — |
| Depreciation And Amortization In Income Statement | 63.84 Cr | 56.35 Cr | 62.51 Cr | 55.96 Cr | — |
| Amortization | 2.74 Cr | 1.68 Cr | 2.75 Cr | 3.16 Cr | — |
| Depreciation Income Statement | 61.09 Cr | 54.68 Cr | 59.76 Cr | 52.80 Cr | — |
| Selling General And Administration | 57.97 Cr | 48.83 Cr | 56.87 Cr | 57.72 Cr | — |
| Selling And Marketing Expense | 18.09 Cr | 17.34 Cr | 17.52 Cr | 15.42 Cr | — |
| General And Administrative Expense | 39.88 Cr | 31.49 Cr | 39.35 Cr | 42.30 Cr | — |
| Rent And Landing Fees | 9.85 Cr | 9.74 Cr | 8.87 Cr | 6.14 Cr | — |
| Gross Profit | 765.51 Cr | 643.42 Cr | 840.93 Cr | 633.66 Cr | — |
| Cost Of Revenue | 870.08 Cr | 792.81 Cr | 830.37 Cr | 770.75 Cr | — |
| Total Revenue | 1.64K Cr | 1.44K Cr | 1.67K Cr | 1.40K Cr | — |
| Operating Revenue | 1.64K Cr | 1.44K Cr | 1.67K Cr | 1.40K Cr | — |
| Impairment Of Capital Assets | — | 0.00 | 0.50 Cr | 3.91 Cr | 1.27 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Camlin Fine Sciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.